Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Saved in:
| Title: | Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma. |
|---|---|
| Authors: | Ewen T; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Husain A; Novo Path and Cellular Pathology., Stefanos N; Pathology, Addenbrookes Hospital, Cambridge University NHS Trust, Cambridge, UK., Barrett P; Pathology, University Hospitals of North Durham, Durham, UK., Jones C; Novo Path and Cellular Pathology., Ness T; Novo Path and Cellular Pathology., Long A; Novo Path and Cellular Pathology., Horswell S; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Francis Crick Institute, London, UK., Bosomworth H; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Lowenstein J; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Richardson G; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Swan D; AMLo Biosciences, Newcastle upon Tyne, UK.; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK., McConnell A; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Rose A; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Andrew T; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Reynolds N; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK., Malvehy J; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Carrera C; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Alos L; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Mailer S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Helm T; Division of Dermatology, Buffalo Medical Group, Williamsville, NY, USA.; Department of Dermatology, Penn State Hershey, Hershey, Pennsylvania, USA., Ding L; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Bogner P; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Podlipnik S; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., Puig S; Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain., McArthur GA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Paragh G; Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Labus M; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK., Sloan P; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; Novo Path and Cellular Pathology.; AMLo Biosciences, Newcastle upon Tyne, UK., Armstrong JL; AMLo Biosciences, Newcastle upon Tyne, UK.; Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK., Lovat PE; Translation and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; AMLo Biosciences, Newcastle upon Tyne, UK. |
| Source: | The British journal of dermatology [Br J Dermatol] 2024 Mar 15; Vol. 190 (4), pp. 549-558. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2133 |
|---|---|
| DOI: | 10.1093/bjd/ljad459 |
